Atrial fibrillation/flutter induced by implantable ventricular shocks: differ- ence between epicardial and endocardial energy de- livery. J Cardiovasc Electrophysiol 1997;8(1):35-41.RG, Baranowski GM, Prystowsky EN. Atrial fibrillation/flutter induced by implantable ventricular defibrillator shocks: ...
All research was performed in accordance with relevant guidelines and regulations. Among the 1782 patients, those with potential cardiac source of embolism (PCSE; n = 261, which including persistent atrial fibrillation (AF)/flutter (n = 190), paroxysmal AF (n = 45), sick sinus ...
doi:10.1111/j.1540-8167.1996.tb00595.xBRIAN OLSHANSKYLoyola University Medical CenterJournal of Cardiovascular ElectrophysiologyOlshansky B (1996) Dofetilide versus quinidine for atrial flutter: vive 1a difference. J Cardiovasc Electrophysiol 7:809–827...
Introduction Guidelines recommend trans-esophageal echocardiography (TEE) for patients with atrial fibrillation (AF) or atrial flutter (AFL) for >48 h, due to risk of intracardiac thrombus formation. With growing evidence that AFL in adults with structurally normal hearts has less thrombogenic ...
Using the National Inpatient Sample (NIS), we performed a difference-in-differences analysis of the association between legalization and hospitalization rates for 6 cardiovascular diagnoses, a positive control (cannabis-related diagnoses), and 2 negative control diagnoses (opioid-related and urinary ...
The prevalence of thrombus in the entire cohort was 9.5%, with no difference between AF (13.8%) and AFL groups (7.9%), p = .46. Patients with thrombus demonstrated no difference in age, systemic ventricular function, cardiac complexity, or CHADS2/CHA2DS2VASc score at presentation. ...